ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

FDA's DHF per the CGMPs 2015 - DHF, DMR, DHR, Technical File and Design Dossier - Key Requirements and Future Directions

Date2015-05-12

Deadline2015-05-11

VenueOnline event, USA - United States USA - United States

KeywordsWebinar; Compliance training webinar; Regulatory training

Websitehttp://bit.ly/1G7GQxD

Topics/Call fo Papers

Overview:
It will also consider the European Union's MDD TF/DD requirements, and evaluate the documents' differing purposes / goals, as well as the two different device classification schemes. Required and desirable contents will be discussed.
Also considered: Areas requiring frequent re-evaluation / update; Similarities and differences; Future trends; Typical DHF Table of Contents; Technical File or Design Dossier Table of Contents; The importance and usefulness of the "Essential Requirements"; Structure of the "Declaration of Conformity"; self-declaring or N-B reviewed; Parallel approaches to development. Finally, the differing approaches to file audits by the FDA and the Notified Body will be discussed.
Why should you attend: One of our most popular webinars, continuously updated with the latest U.S. FDA and European Union requirements. As U.S. companies go global, they must meet different product design documentation. The cGMPs mandate Design Control and the Design History File (DHF). In order to sell globally, the EU's CE-marking documentation is a requirement - the Technical File or Design Dossier. Currently they serve different purposes, support different goals, but the TF/DD is moving in the direction of the DHF. And the DHF is adapting to some of the features of the TF/DD. And how / where do the DMR and DHR fit? Being aware of the similarities and differences in the files and their individual documents can further concurrent development and/or updates to both.
Areas Covered in the Session:
The EU's MDD and the Technical File / Design Dossier
Device Classification - U.S. FDA vs. EU MDD
Design Control 'Over Time' vs. a Product's 'Snapshot in Time' - Differing Philosophies
DHF "Typical" Contents and Deliverables
The DMR and DHR / Lot / Batch Record
TF / DD Required Contents
Parallel Approaches to Documentation - Teams
FDA and NB Audit Focus
Who Will Benefit:
Senior management in Drugs, Devices, Biologics, Dietary Supplements
QA
RA
R&D
Engineering
Production
Operations
Marketing
Speaker Profile
John E. Lincoln is a medical device and regulatory affairs consultant.
Compliance4All
Adam Fleaming
Phone: +1-800-447-9407
Event Link: http://bit.ly/1G7GQxD
support-AT-compliance4all.com
www.compliance4all.com

Last modified: 2015-03-31 18:13:08